Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
A SPAC I Acquisition Unit | ASCAU | 9. mai 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | 9. mai 2024 | 11.10 | +0.09 |
A-Mark Precious Metals | AMRK | 9. mai 2024 | 40.86 | +7.10 |
a.k.a Brands | AKA | 9. mai 2024 | 22.00 | +5.26 |
A.O Smith | AOS | 9. mai 2024 | 86.39 | +0.95 |
A10 Networks | ATEN | 9. mai 2024 | 15.50 | +0.58 |
A2Z Smart Technologies | AZ | 9. mai 2024 | 0.39 | +1.32 |
AAA - A Rated Corporate Bond Ishares | QLTA | 9. mai 2024 | 46.68 | +0.11 |
Aadi Bioscience | AADI | 9. mai 2024 | 1.88 | +2.17 |
AAON | AAON | 9. mai 2024 | 77.75 | +0.99 |
AAR | AIR | 9. mai 2024 | 72.09 | +0.14 |
Abacus Life | ABL | 9. mai 2024 | 11.95 | -0.83 |
Abbott Laboratories | ABT | 9. mai 2024 | 104.67 | -0.26 |
AbbVie | ABBV | 9. mai 2024 | 160.40 | -0.03 |
AbCellera Biologics | ABCL | 9. mai 2024 | 3.95 | +2.86 |
Abeona Therapeutics | ABEO | 9. mai 2024 | 4.45 | +1.14 |
Abercrombie & Fitch | ANF | 9. mai 2024 | 132.33 | +2.90 |
Aberdeen Asia-Pacificome Fund | FAX | 9. mai 2024 | 2.61 | +0.38 |
Aberdeen Australia Equity Fund | IAF | 9. mai 2024 | 4.34 | -0.11 |
Aberdeen Emerging Markets Fund | AEF | 9. mai 2024 | 5.20 | 0.00 |
Aberdeen Global Fund | FCO | 9. mai 2024 | 5.67 | +0.09 |
Aberdeen Global Infrastructure | ASGI | 9. mai 2024 | 18.24 | +1.56 |
Aberdeen Income Credit Strategies Fund | ACP | 9. mai 2024 | 6.75 | +0.45 |
Aberdeen Income Credit Strategies Pref | ACP-A | 9. mai 2024 | 25.15 | +5.54 |
Aberdeen Japan Equity Fund | JEQ | 9. mai 2024 | 6.00 | +0.10 |
Abits Group | ABTS | 9. mai 2024 | 0.81 | +0.86 |
Abivax SA - American Depositary Shares | ABVX | 9. mai 2024 | 14.15 | -0.91 |
Able View Global | ABLV | 9. mai 2024 | 1.60 | +1.27 |
ABM Industries | ABM | 9. mai 2024 | 45.37 | +0.98 |
Abrdn Global Dynamic Dividend Fund | AGD | 9. mai 2024 | 9.61 | +0.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.